F043 Treating Tumors and Inflammatory Skin Diseases with Immunomodulators and Biologics
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
The exponential growth of our understanding of immune system pathways has been equally paralleled by the development of immunomodulators that can impact the biological underpinnings of diseases instead of just symptoms. As we move towards a more personalized therapeutic approach, dermatologists must be aware of the multitude of therapies that exist, both on and off-label, and where current ongoing research is heading in order to ensure that patients are provided with all available and most appropriate treatments. Knowledge of the biological mechanisms of these treatments will improve utilization and application, as well as patient partnering and quality of care.
LEARNING OBJECTIVES
Categorize and differentiate dermatoses based on their inflammatory versus neoplastic origin and their potential responses to topical and systemic immunotherapies.
Recognize potential applications of immune-based therapies outside of conventional uses.
Select therapeutic options to modify a disease process in addition to alleviate symptoms based on the immune mechanisms that create them.
SCHEDULE
5:00 PM
Introduction/Welcome
Adam J. Friedman, MD, FAAD
5:02 PM
Biologics/Immunomodulators in Pediatric Dermatology
Colleen Cotton, MD, FAAD
5:19 PM
Immunomodulators for Chronic Spontaneous Urticaria
Adam J. Friedman, MD, FAAD
5:36 PM
Immunomodulators for Skin Cancer
Vishal Patel, MD
5:53 PM
Q&A
Adam J. Friedman, MD, FAAD, Colleen Cotton, MD, FAAD, Vishal Patel, MD
6:02 PM
Immunomodulators for Granulomatous Diseases
George Han, MD, PhD, FAAD
6:19 PM
Immunomodulators for Scarring Alopecias
Crystal Aguh, MD, FAAD
6:36 PM
Paradoxical Rashes from Biologics/Immunomodulators
Sheila Shaigany, MD, FAAD
6:51 PM
Q&A
Crystal Aguh, MD, FAAD, George Han, MD, PhD, FAAD, Sheila Shaigany, MD, FAAD
SPEAKERS
Crystal Aguh, MD, FAAD
Colleen Cotton, MD, FAAD
Adam J. Friedman, MD, FAAD
George Han, MD, PhD, FAAD
Vishal Patel, MD
Sheila Shaigany, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Crystal Aguh, MD, FAAD
Eli Lilly and Company – Consultant(Fees); Myovant Sciences – Advisory Board(Fees); Olaplex – Advisory Board(Fees); Pfizer Inc. – Consultant(Fees); UpToDate, Inc – Other(Fees);
Colleen Cotton, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Salary); HS Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Inner Archways LLC – Advisory Board(Other Financial Benefit); Janssen Biotech – Advisory Board(Other Financial Benefit); LEO Pharma, US – Advisory Board(Honoraria); Novartis – Other(Other Financial Benefit); Pierre Fabre – Consultant(Honoraria); Regeneron – Investigator(Salary); TARGET Pharma – Investigator(Salary); UCB – Other(Other Financial Benefit);
Adam J. Friedman, MD, FAAD
AbbVie – Speaker/Faculty Education(Honoraria); Aclaris Therapeutics Inc. – Advisory Board(Honoraria); Amgen – Speaker/Faculty Education(Honoraria); BMS – Speaker(Honoraria); CeraVe – Other(Grants/Research Funding); Dermavant Sciences, Inc. – Advisory Board(Honoraria); Eli Lilly – Other(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria); Galderma – Other(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Greenway Therapeutix – Advisory Board(Stock); Hoth Therapeutics – Advisory Board(Honoraria); Incyte – Speaker(Honoraria); janssen – Other(Grants/Research Funding); Janssen Biotech – Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Johnson and Johnson Consumer Products Company – Consultant(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria), Consultant(Honoraria); Medscape – Speaker/Faculty Education(Honoraria); Novartis – Advisory Board(Honoraria); Orlando Dermatology Aesthetic & Clinical (ODAC) – Speaker(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Regeneron – Speaker/Faculty Education(Honoraria); Sanova Works – Consultant(Honoraria);
George Han, MD, PhD, FAAD
AbbVie – Speaker(Honoraria); Amgen – Advisory Board(Honoraria); Avillion – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Advisory Board(Honoraria); Celgene – Investigator(Grants/Research Funding); DermTech Inc. – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Hikma Pharmaceuticals – Speaker/Faculty Education(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); MC2 Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Othro Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sonoma Pharmaceuticals – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); UCB – Advisory Board(Honoraria);
Vishal Patel, MD
Almirall – Advisory Board(Honoraria); Castle Biosciences, Inc – Advisory Board(Honoraria); Gerson Lehrman Group – Consultant(Fees); PHD Biosciences – Consultant(Fees); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Science 37, Inc. – Stockholder(Stock);
Sheila Shaigany, MD, FAAD
No financial relationships exist with ineligible companies.